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Abstract.  To begin to understand the nature of myosin 
subunit assembly, we determined the region of a ver- 
tebrate sarcomeric myosin heavy chain required for 
binding of light chain 1. We coexpressed in Esche- 
richia coli segments of the rat alpha cardiac myosin 
heavy chain which spanned the carboxyl terminus of 
subfragment 1 and the amino terminus of subfragment 
2 with a full-length rat cardiac myosin light chain 1. A 
16 amino acid region of the myosin heavy chain (resi- 
dues 792-808)  was shown to be required for myosin 
light chain 1 binding in an immunoprecipitation assay. 
M 
YosiN  is  an asymmetric  hexamer  comprised  of 
two heavy chains (210 kD) and two pairs of light 
chains (18-25 kD). In smooth muscle, invertebrate 
muscle and vertebrate nonmuscle myosin, myosin light chain 
2 (MLC2) ~  regulates the actin-activated ATPase of myosin 
in response to the calcium concentration of the cell (for re- 
views see Kamm and Stull,  1985; Citi and Kendrick-Jones, 
1988). The role of  MLC1 in myosin function is less clear (see 
Wagner and Giniger,  1981; Sivaramakrishnan  and Burke, 
1982). However, isoforms of MLC1 have  been shown to be 
associated  with  different  shortening  velocities  of skeletal 
muscle (Sweeney et al.,  1988). 
The interactions of  the subunits of  myosin are not precisely 
defined, but both biochemical and electron microscopic stud- 
ies suggest that MLCs bind near the junction of the sub- 
fragments 1 and 2 ($1 and $2). Scallop myosin reacted with 
anti-light  chain  antibodies  demonstrates  MLC2  binding 
near the head-rod junction (Flicker et al., 1983). Similar po- 
sitions were noted for vertebrate MLC2, with MLC1 binding 
distally to MLC2, in the S1  head (Tokunaga et al.,  1987; 
Katoh  and Lowey, 1989). Proteolytic  peptides  of myosin 
heavy chain (MHC) from the carboxyl terminus of the S1 
head bind MLC (Szentkiralyi,  1984; Mitchell et al., 1986). 
Burke et al. (1983) also implicated the carboxyl terminus of 
the S1 head by abolishing MLC1 binding with proteolytic di- 
gestion of a 3-kD segment from the S1-$2 junction. Sellers 
and Harvey (1984) used gel overlay to assign the light chain 
binding sites to 26 kD at the carboxyl terminus of smooth 
muscle  myosin $1.  However, Okamoto et al.  (1986) have 
shown that  MLC1 binds  near the  site of ATP binding on 
smooth muscle myosin. In the scallop it has been shown that 
exchange of  MLC1 with exogenously added MLC1 can occur 
only in the absence of MLC2 (Ashiba and Szent-Gyorgyi, 
1985). This finding, coupled with the observation that the 
1. Abbreviations used in this Paper: MHC, myosin heavy chain; MLC, myo- 
sin light chain; S1 and $2,  subfragment 1 and 2, respectively. 
sulfhydryl groups of scallop MLC1 are only available for la- 
beling in the absence of MLC2, suggests that MLC1 lies be- 
tween MLC2 and MHC (Walliman  and Szent-Gyorgyi, 1981; 
Hardwicke et al.,  1982). 
The use of recombinant DNA methods to produce myosin 
segments that have precisely defined sequences would be of 
great use in mapping the interactions of myosin subunits. A 
portion of  the Caenorhabditis elegans unc54 MHC gene cor- 
responding  to  S1  was  expressed  in Escherichia coli and 
shown to interact with MLCs in a gel overlay system (Mitch- 
ell et al.,  1989). This approach identified the extreme car- 
boxyl terminus of S1, (residues 848-886  on the C. elegans 
unc54 MHC) as the region of the MHC which is responsible 
for the MHC :MLC interaction. This approach, while useful, 
studies the association of MLC with a denatured MHC and, 
therefore,  may not reflect all the possible  interactions  be- 
tween MHC and MLC. We have shown previously that coex- 
pression of soluble MHC and MLC1 results in their coas- 
sembly with the appropriate stoichiometry (McNally et al., 
1988). In the present study, the interaction ofa nondenatured 
MHC and MLC1 was studie2t  using E. coli coexpression of 
the rat alpha cardiac MHC along with the full-length rat ven- 
tricular MLC1. Deletions spanning $2 and the 20-kD region 
of S1 were used to identify a region responsible for MLC1 
binding on the MHC. This approach,  which examines the 
binding of two proteins in solution which are associated in 
vivo, identified 16 amino acids toward the carboxyl end of 
S1 as necessary for MLC1 binding. 
Materials and Methods 
Construction of  Expression Plasmid 
A eDNA encoding the first 3111 bp of the rat alpha cardiac MHC (McNally 
et al.,  1989a) was digested with BglI, treated with T4 DNA polymerase, 
digested with HindIII, and ligated into the expression vector PINIAI that 
had been digested with EcoRI, blunted, and cut with HindIII (Masui et al., 
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Klenow fragment, digested with HindIII, and ligated into pKK233-2 (Phar- 
macia Fine Chemicals, Piscataway,  NJ) that had been digested with EcoRI, 
treated with Klenow,  and then digested with HindIII. This placed the ex- 
pression of the MHC sequences under the control of the tac promoter (de- 
Boer et al., 1983). This resulted in alteration of the first amino acids of the 
alpha cardiac MHC from MTDAQM to MLGNLA. The termination codons 
are provided by the expression vector. 
A full-length eDNA for the rat ventricular MLC1 cDNA (McNally et al., 
1989b) was engineered by site-directed mutagenesis with the oligonucleo- 
tide 5'GATTACAGCTCCATCK?d2CCCC3' to contain an  Ncol  site at  its 
amino-terminal methionine codon. The mutagenized plasmid was digested 
with NcoI and  HindIII  and ligated into a  similarly digested pKK233-2 
(Pharmacia Fine Chemicals); a native MLC1 sequence was generated. The 
portion of  this expression  construct containing the promoter, coding regions, 
and terminator sequences was placed on the same plasmid with the se- 
quences expressing the alpha cardiac MHC by digesting both with SphI, 
purifying the appropriate fragments and ligating them. 
Construction of Deletion Mutants 
Deletions of  the 3' end of  the 3.1-kb plasmid of  the alpha cardiac MHC were 
constructed using  an exonuclease III/S1  nuclease system (Erase-a-base; 
Promega Biotec, Madison, WI), (Henikoff, 1984),  and sequenced (Kraft et 
al.,  1988).  Those deletions that retained a HindIII site and terminated in 
the desired region, spanning the 20-kD terminal portion of  S1 and the amino 
terminus of $2, were selected and subcloned into the expression vector to 
produce the deletions of  the MHC along with the full-length MLC1 protein. 
Cell Growth and Induction 
E. coli carrying the expression construct plasmids were grown in LB and 
50 #g/ml ampicillin at 37°C until reaching an ODs95 of 0.7 at which point 
IPTG (isopropylthiogalactoside) was added to a final concentration of 0.2 
mM. The E. coli were grown an additional 30 min and then harvested and 
washed as previously described (McNally et al.,  1988).  The E.  coli were 
resuspended in a lysis buffer containing the following: 50 mM Tris-HC1, 
pH 7.5, 100 mM KC1, 5 mM EDTA, pH 7.5, 5% (wt/vol) sucrose, 0.3 mM 
PMSF, 0.5 #g/ml leupeptin, 0.7 #g/ml pepstatin, 0.2 mM TPCK, 0.2 mM 
TLCK, and 1 mM DTT. 500 ml of E. coli culture (,'ol g wet weight) was 
resuspended in 15 ml of lysis buffer. The cell suspension was passed three 
times through a chilled French pressure cell (40 mi size) at 1,000  lb/in  2 
The lysate was then centrifuged at 30,000 g for 45 min to remove the insolu- 
ble debris. The quantity of MHC expressed by the various bacterial strains 
was determined by an ELISA assay with F59 antibody (see below). MLCI 
quantities in bacterial strains were determined by immunoblot analysis with 
MF5 (see below) compared to known quantities of rabbit $1. 
Immunoprecipitations 
Immunoprecipitations were made in two ways.  The first used Pansorbin 
formalin-fixed Staphylococcus  aureus  cells (Calbiochem-Behring Corp., 
La Jolla, CA). The Pansorbin cells were prepared by mixing 30 tzl of cells 
with 1 ml 0.1% BSA in TBS (150 mM NaCI, 50 mM Tris, pH 7.7) twice, 
pelleting for 1 min in a microfuge to collect the cells. The blocked cells were 
then incubated with 25/A of 1 mg/ml rabbit anti-mouse IgG (Cappel-Orga- 
non, West Chester, PA) for 1 h on ice. These cells were washed once with 
200/A of TBS and then resuspended in 100/~g of purified F59 antibody 
(Miller et al., 1989; generous gift ofF. Stockdale, Stanford University) for 
a minimum of 2 h on ice. The cells were washed twice with 250/~1 of TBS 
and then incubated with lysate supernatants of E. coli expressing deletions 
of  MHC and full-length MLC1 overnight on ice. The immunoprecipitations 
were pelleted and washed three times with TBS plus 1 mM DTT. The final 
pellet was resuspended in SDS-PAGE sample buffer and electrophoresed  on 
a 15 % Laernmli (1970) gel. A duplicate gel was transferred to nitrocellulose 
by standard techniques (Towbin et al.,  1979),  and immunoblotted with 
MF5, an anti-MLC2 monoclonal antibody that also cross-reacts with car- 
diac MLC1  (generous gift of D.  Fischman,  Cornell University Medical 
School, New York),  (Shimizu et al.,  1985). 
For measurements of  the stoichiometry of MHC:MLC1, partial fraction- 
ation of the bacterial extracts was carded out before incubation with an 
anti-myosin immunoaffinity resin. After French press lysis of 500 ml cul- 
ture ofE. coli cells into 10 ml of lysis buffer (6% sucrose, 225 mM NaCI, 
5 mM Tris pH 7.7, 0.5 mM DTT, protease inhibitors as above) a high speed 
centrifugation step was carried out (100,000 g for 37 rain at 40C). The su- 
pernatant was incubated with 20 rrd of DE52 resin (equilibrated with lysis 
Figure 1. Plasmid forcoexpres- 
sion of rat alpha cardiac MHC 
and rat ventricular MLCI. (Mc- 
Nally  et  al.,  1989a,b).  Two 
separate  copies of the IPTG- 
inducible tac promoter are pres- 
ent on the plasmid and drive 
expression of the two subunits 
of myosin. Deletions of  the rat 
alpha cardiac MHC were gen- 
erated by exonuclease III  di- 
gestion followed by  subclon- 
ing  at  the  BglII  and  HindlII 
sites  shown  in  the  MHC.  B, 
BgllI; H,  HindlI. 
buffer) to remove nucleic acid. The material not bound to DE52 was sub- 
jected to high speed centrifugation (100,000 g for 96 rain at 4"C). 6 ml (cor- 
responding to ,~35%  of the original culture) of this supernatant was in- 
cubated overnight at 4°C in batch with 0.5 ml of  Sepharose covalentiy linked 
to the anti-MHC IgG, F59, at a concentration of 1.9 mg/ml. The resin was 
washed with 15 ml of a buffer containing 0.4 M (NI-h)2SO4, 0.5 mM DTT, 
0.25 mM EDTA, 50 mM Tris pH 7.7 at 4°C. 300/~1 of lx  Laemmli buffer 
was added to the resin. The mixture was heated at 100*C fur 5 min before 
loading (25 ~tl) on a polyacrylamide gel. Each sample was run on duplicate 
gels, along with chymotryptic S1 from rabbit skeletal myosin as a control. 
One gel was stained with Coomassie brilliant blue and the other was im- 
munoblotted with MF5 and F59 (see above). The lanes of the Coomassie 
brilliant blue-stained gel were scanned with a quantitative scanning laser 
densitometer (Pharmacia LKB UltroScan, Piscataway,  NJ). The areas un- 
der the peaks were evaluated  using the Gelsean XL software program. The 
MHC and MLC1 peaks were obtained for chymotryptic SI and their ratio 
compared to those obtained from various bacterial constructs. The ratio for 
chymotryptic S1 is 1.1 (range 0.9--1.2). The ratios for D4, D3, I)2, D6, and 
D6 and MLCI  are indistinguishable and show a  range of 0.9-1.1 
Results 
Coexpression of  MLC1 with Deletions of  MHC 
An E. coli expression vector was constructed to express de- 
letions of the  rat alpha  cardiac  MHC  along  with the  full- 
length rat ventricular  MLC1.  Both of the subunits of myosin 
were expressed from a single plasmid with two copies of the 
isopropylthiogalactosidase  (IPTG)-inducible  tac  promoter 
(deBoer et al.,  1983).  A  diagram  of this plasmid is shown 
in Fig.  1. A  series of deletions was generated using exonu- 
clease III digestion ofa 3.l-kb cDNA for the rat alpha cardiac 
MHC. Progressive deletions that retained the proper cloning 
Table L Deletion Expression Plasmids of  the Rat Alpha 
Cardiac MHC to Map the MLC1 Binding Site on the MHC 
Predicted 
Clone  bp  AA  molecular  weight  Binds MLC1 
D-1  2,145  715  81,185  - 
DO  2,205  735  83,532  - 
D1  2,376  792  89,805  - 
D6  2,424  808  93,326  + 
D2  2,496  832  95,058  + 
D3  2,622  874  100,042  + 
134  3,096  1,032  118,310  + 
Listed above is the name of the deletion of the rat alpha cardiac MHC cDNA, 
its length in nucleotides (bp) and amino acids (AA) and the predicted molecular 
weight  of the expressed segment. Shown at the far right are the results  of 
MLC1  binding  determinations. 
The Journal of Cell Biology,  Volume 113, 1991  586 Figure 2. Expression of the deletions of the rat alpha cardiac MHC and rat ventricular MLC1 in E  coli. Shown are whole cell lysates 
of bacteria expressing MHC deletions and full-length MLC1. (A) 10% Coomassie blue-stained SDS-PAGE. (B) Immunoblot of 10% SDS- 
PAGE where the top half was reacted with F59, an anti-MHC monoclonal antibody (Miller et al., 1989). The lower half of the immunoblot 
was reacted with MF5, an anti-MLC monoelonal antibody (Shimizu et al., 1985). MF5 also recognizes a bacterial protein that migrates 
just above the MLC1 band. Lane 1, a bacterial strain expressing the D2 MHC construct, but not expressing MLC1; Lanes 2-7are extracts 
of E. coli expressing the deletions of the MHC with the full-length MLC1 (-1D, DO, D1, D2, D3, and D4, respectively). 
sites were expressed in E.  coli.  Seven deletions were con- 
structed to span the region (2,145-3,096 bp), which corre- 
sponds to the carboxyl terminus of the 20-kD tryptic region 
of the S1 head to the middle of the $2 region (amino acid 
residues 715-1,032). Table I summarizes the lengths of the 
MHC deletions and the predicted molecular weights. 
A substantial portion of both MHC and MLC1 were found 
in the soluble fraction of an E. coli lysate after a nondeter- 
gent lysis (data not shown). The MLC1 protein was produced 
at '~5 mg/liter ofE. coli (2 g wet weight) which was in molar 
excess of the MHC deletions (also ,x,5 mg/liter of E. coli). 
The various MHC deletions were produced at levels which 
varied only slightly from each other. Expression of the MHC 
and MLC1 from these constructs is shown in Fig. 2. The dele- 
tions of the alpha cardiac MHC all appear to migrate at the 
molecular weights predicted from their amino acid sequence. 
E. coli expressing each of the MHC deletions and the full- 
length MLC1  were grown,  induced and lysed under non- 
detergent conditions. The cell debris was pelleted, and the 
supernatant was used to study the association of MHC and 
MLC1. Immunoprecipitations with an anti-MHC monoclo- 
nal antibody, F59 (Miller et al.,  1989) were used to study 
the interaction of MHC and MLC1. The shortest three con- 
structs,  -ID,  DO, and D1  were found not to be associated 
with any MLC1 as determined by Coomassie blue-stained 
SDS-PAGE as  well as immunoblot analysis with an anti- 
MLC monoclonal antibody, MF5  (Shimizu et al.,  1985). 
The four longer constructs, D6, D2, D3, and I)4, were found 
to associate with MLC1.  The results for the D6 construct 
compared with DO can be seen in Fig. 3. D6 (amino acids 
1-808) is the shortest segment of the MHC which can bind 
MLC1. The ratio of MHC to MLC1 was quantitated by den- 
sitometric scans of Coomassie blue-stained gels, using chy- 
motropic  S1  as  a  standard  (see Materials  and  Methods). 
From this analysis, we conclude that the region between D1 
and D6 is necessary for the association of MHC and MLC. 
Comparison of the MLC1 Binding Site among MHCs 
A  comparison of the sequence of residues 792-808 on the 
rat alpha cardiac MHC, with MHCs from lower eukaryotes, 
vertebrate nonmuscle,  smooth  muscle,  and  striated  mus- 
cles revealed only one invariant residue  (Fig.  4).  On  the 
other hand,  8 of the 16 residues in the putative light chain 
binding site are conserved in all of these vertebrate striated 
muscle MHC's. 
Discussion 
The deletion analysis  presented here suggests  that  amino 
McNally et al.  Cardiac Myosin Subunit Binding Site  587 Figure 3. Analysis of MHC deletions for association with MLC1. 
Shown  are  duplicate  15%  polyacrylamide  gels  stained  with 
Coomassie brilliant blue (A) or blotted and reacted with monoclo- 
hal antibodies directed against MHC (top panel) and MLCI (bot- 
tom panel) (B). Lane 1, immunobeads with no bacterial extract. 
Lanes 2 and 3 are immunoprecipitations of bacterial extracts (DO 
and D6, respectively, both coexpressing MLC1) with F59 antibody 
coupled to Sepharose. Vertical arrows mark the positions of  the im- 
munoglobulins from the monoclonal antibody (IgHC and IgLC, im- 
munoglobulin heavy chain and light chain,  respectively) and the 
myosin subunits retained by the MHC antibody. 
acids 792-808 of cardiac MHC are necessary for its interac- 
tion with MLC1. One implication of our results is that other 
regions of S1 and the amino terminus of $2 are not necessary 
for the association with MLC1. It should be kept in mind that 
it  has  not  been  established  that  these  16  residues  are 
sufficient for MLC1 binding. It is possible that the inability 
of the shorter MHC constructs (-1D, DO, and D1) to bind 
MLC1  is  due  to  conformational changes  resulting  from 
removal of amino acids 792-808. However, studies of Szent- 
kiralyi (1984)  showed that a  14-kD  peptide is  capable of 
binding MLC1, suggesting that very distal sequences are not 
required for the stoichiometric binding. The identification of 
this region of the MHC as the MLC1 binding site is in good 
agreement  with previous studies on invertebrate  myosin  which 
used different approaches (Mitchell et al.,  1986,  1989), as 
well as earlier proteolytic cleavage studies (see Burke et al., 
1983; Szentkiralyi,  1984). 
The MLC1  binding site identified by this  study lies 30 
amino acids amino-terminal the the proline residue thought 
to be the junction between S1 and $2 as defined by McLach- 
lan  and Karn (1982).  The D6 deletion, which terminates 
at  residue  808,  migrates  electrophoretically similarly  to 
cardiac muscle S1 derived from proteolysis by chymotrypsin 
(data not shown) and corresponds exactly to the terminal res- 
idue of chymotryptic S1 from chicken skeletal muscle as de- 
termined by Malta et al. (1987). This confirms the prediction 
that the MLC1 binding site is near the S1-$2 junction. Immu- 
noelectron microscopy studies that use anti-MLC antibodies 
have identified the MLC1  binding region to be somewhat 
distal to the MLC2 binding site at the head-rod junction 
when viewing the rotary shadowed myosin image (Katoh and 
Lowey, 1989). This would argue that the 16 amino acid re- 
gion  identified by the  present experiments would lie up- 
stream of the head-rod junction on the rotary shadowed im- 
age.  E.  coli expression experiments with amino-terminally 
truncated portions of the Acanthamoeba myosin II sequence 
have predicted that the S1-$2 junction may actually lie within 
the head of myosin when viewed as a rotary-shadowed image 
in the electron microscope (Rimm et al., 1989). Their results 
would place the MLC1 binding site within the head as op- 
$1  $2  LMM 
25  50  20 
R  K  T  A  M  R  K  Y  Y  Y  E  V  K  K  G  G  Acantha my I 
R  A  F  L A  R  R  M  Y  D  K  M  R  E  Q  T  Acantha my II 
R  G  W  I  A  R  K  V  Y  K  Q  A  R  E  H  T  Dictyo  my II 
R  W  H  L  G  L  K  D  R  K  R  R  M  E  Q  R  C.  elegans 
R  G  Y  L  A  R  K  A  F  A  K  R  Q  Q  Q  L  chick  smooth 
R  G  Y  L  A  R  K  A  F  A  K  R  Q  Q  Q  L  human  nonmuscle 
R  G  F  L  M  R  V  E  F  K  K  M  M  E  R  R  chick  embryonic 
R  G  F  L  M  R  V  E  F  Q  K  M  V  Q  R  R  human  embryonic 
R  G  F  L  M  R  V  E  Y  Q  K  M  L  Q  R  R  human  perinatal 
R  G  F  L  M  R  V  ~  F  Q  K  M  M  Q  R  R  rat  embryonic 
R  G  V  L  S  R  M  E  F  K  K  L  L  E  R  R  rat beta 
R  G  Q  L  M  R  I  E  F  K  K  M  V  E  R  R  rat  alpha 
Figure  4.  Evolutionary  comparison  of the  MLC1 
binding site. A linear schematic of the MHC is shown 
above with a line indicating the location of the  16 
amino acid MLC1 binding site. This region, residues 
792-808,  is  shown below from several MHC  se- 
quences. Shown are the Acanthamoeba MHCI (Ham- 
mer et al., 1986); Acanthamoeba MHCII (Hammer et 
al.,  1987); Dictyostelium  mhca,  (Warrick et  al., 
1986); C. elegans  uric54  (McLachlan and Karn, 1982); 
chicken  smooth  muscle  MHC  (Yanigisawa et  al., 
1987); human nonmuscle MHC (Saez et al.,  1990); 
chicken  embryonic  skeletal  MHC  (Molina  et  al., 
1987); human embryonic (Eller et al.,  1989); hu- 
man perinatal skeletal MHC (Karsch-Mizrachi et al., 
1990); rat embryonic MHC (Strehler et al., 1986); rat 
beta cardiac MHC (Kraft et al., 1989), and rat alpha 
cardiac MHC (McNaUy  et al., 1989a). Dots are shown 
below the hydrophobic residues. 
The Journal of Cell Biology,  Volume t 13, 1991  588 posed to at the head-rod junction.  It may be that  MLCs, 
while interacting  strongly  with one portion of the MHC, 
span a large region of the MHC. 
Of the 16 amino acids identified by the deletion analysis 
to be necessary for MLC1  binding, 6  are hydrophobic and 
8 are charged.  Since half of the residues are charged, it is 
possible that  the interaction between MHC  and MLC1  is 
ionic, as has been suggested by the work of Zaager and Burke 
(1988a,b).  The sequence of this region is highly conserved 
among vertebrate  striated muscle MHC's where 8 of the 16 
amino acids are identical. However, only one residue is abso- 
lutely conserved among all sequenced MHC's.  This compar- 
ison included MHC's from evolutionarily distant organisms, 
such as the lower eukaryotes, Acanthamoeba and Dictyoste- 
lium. The Acanthamoeba MHC I is thought to be associated 
with only  one  MLC  (for  review  see  Korn  and  Hammer, 
1988).  The different  light chain binding properties of the 
MHC I class of molecules may be reflected in the divergence 
of their sequences in the MLC1  binding region. 
All three myosin subunits  are encoded by multiple genes 
in vertebrates.  Multiple isoforms of MHC and MLC may be 
present in a single cell (for a review see Bandman,  1985). 
The work presented here suggests that the assembly of these 
proteins may be dictated only by their primary sequence. To 
understand  further the assembly of myosin, experiments are 
in progress to determine the binding site on the myosin mole- 
cule for MLC2 by constructing bacterial strains coexpress- 
ing all three myosin subunits. 
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